Impact of Primary Breast Surgery on Overall Survival of Patients With De Novo Metastatic Breast Cancer: A Systematic Review and Meta-Analysis.
Guillermo VillacampaAndri PapakonstantinouIrma FredrikssonAlexios MatikasPublished in: The oncologist (2023)
Surgery of the primary tumor in patients with de novo MBC does not prolong survival, except possibly in younger/premenopausal patients. Breast surgery should be offered within the context of well-designed clinical trials examining the issue.
Keyphrases
- minimally invasive
- coronary artery bypass
- clinical trial
- metastatic breast cancer
- end stage renal disease
- surgical site infection
- chronic kidney disease
- ejection fraction
- peritoneal dialysis
- randomized controlled trial
- free survival
- acute coronary syndrome
- atrial fibrillation
- phase ii
- study protocol
- placebo controlled